Literature DB >> 10362673

Vasorelaxing effects of atrial and brain natriuretic peptides on coronary circulation in heart failure.

T Matsumoto1, A Wada, T Tsutamoto, T Omura, H Yokohama, M Ohnishi, I Nakae, M Takahashi, M Kinoshita.   

Abstract

Natriuretic peptide (NP) receptor has been postulated to be downregulated under a high concentration of atrial NP (ANP) in congestive heart failure (CHF), but limited information is available on how the vascular functional responsiveness to NPs is altered in coronary circulation during CHF. We assessed the relaxant effects of ANP, brain NP (BNP), and other vasodilators in isolated coronary arteries obtained from dogs with and without severe CHF induced by rapid right ventricular pacing. In CHF dogs, plasma ANP and cGMP concentrations were elevated compared with control dogs. In CHF arteries the relaxant effects of ANP and BNP (10(-8) and 10(-7) mol/l) were suppressed compared with control arteries. Nitroglycerin, nitric oxide, 8-bromo-cGMP, and beraprost sodium produced similar concentration-response curves in both arteries. The addition of 10(-7) mol/l ANP increased the level of tissue cGMP in control arteries, but not in CHF arteries. We conclude that there was a specific reduction in the relaxant effects of ANP and BNP in isolated coronary arteries in severe CHF dogs, which suggests the possibility of the downregulation of NP receptors coupled to guanylate cyclase.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10362673     DOI: 10.1152/ajpheart.1999.276.6.H1935

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  3 in total

Review 1.  Beraprost: a review of its pharmacology and therapeutic efficacy in the treatment of peripheral arterial disease and pulmonary arterial hypertension.

Authors:  Ezequiel Balmori Melian; Karen L Goa
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 2.  BNP and Heart Failure: Preclinical and Clinical Trial Data.

Authors:  Emmanuel E Egom
Journal:  J Cardiovasc Transl Res       Date:  2015-03-14       Impact factor: 4.132

3.  The clinical effect of recombinant human brain natriuretic peptide on asymptomatic peri-procedural myocardial injury after percutaneous transluminal coronary angioplasty.

Authors:  Ling Liang; Rong Tang; Qiang Xie; Junyu Han; Weihua Li
Journal:  Sci Rep       Date:  2020-09-28       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.